Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Joshua Aviram"'
Publikováno v:
Journal of Cannabis Research, Vol 4, Iss 1, Pp 1-9 (2022)
Abstract Background Although the worldwide use of medical cannabis (MC) is on the rise, there is insufficient data regarding the long-term stability of phytocannabinoids in the plant material under different storage conditions. Specifically, there is
Externí odkaz:
https://doaj.org/article/7374f0069f6341b4b744dfd9d6e4d6b6
Autor:
Joshua Aviram, Marek Glezerman, Eytan Hayam, Rostislav Belobrov, Shiri Procaccia, David Meiri, Elon Eisenberg
Publikováno v:
Pharmaceuticals, Vol 16, Iss 10, p 1426 (2023)
Background: Clinical studies on medical cannabis (MC) treatment have shown sex-related differences, including higher susceptibility to adverse events among women and greater analgesia among men. Here, we used the Syqe metered-dose inhaler (MDI) and a
Externí odkaz:
https://doaj.org/article/dfa96d2a344e4ccca049346ebb72fca0
Publikováno v:
PAIN Reports, Vol 7, Iss 3, p e1011 (2022)
Abstract. Introduction:. Preliminary clinical studies on medical cannabis (MC) treatment using the Syqe Inhaler showed short-term effectiveness and safety at very low and precise doses of MC. Objectives:. Here, we retrospectively analyzed “real-lif
Externí odkaz:
https://doaj.org/article/cd044a793a214ace8720c06f8df09aad
Autor:
Joshua Aviram, Gil M. Lewitus, Yelena Vysotski, Mahmoud Abu Amna, Anton Ouryvaev, Shiri Procaccia, Idan Cohen, Anca Leibovici, Luiza Akria, Dimitry Goncharov, Neomi Mativ, Avia Kauffman, Ayelet Shai, Gil Bar-Sela, David Meiri
Publikováno v:
Frontiers in Pain Research, Vol 3 (2022)
The use of medical cannabis (MC) to treat cancer-related symptoms is rising. However, there is a lack of long-term trials to assess the benefits and safety of MC treatment in this population. In this work, we followed up prospectively and longitudina
Externí odkaz:
https://doaj.org/article/0e62212239e74aa79ad8acd7045b712e
Autor:
Joshua Aviram, Gil M. Lewitus, Yelena Vysotski, Ben Yellin, Paula Berman, Anna Shapira, David Meiri
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Introduction: Chronic non-cancer pain (CNCP) is one of the most prevalent indications for medical cannabis (MC) treatment globally. In this study, we investigated CNCP parameters in patients during prolonged MC treatment, and assessed the interrelati
Externí odkaz:
https://doaj.org/article/4aae674fae834d45b53b611b07ab17dc
Autor:
Jeffrey Y. Hergenrather, Joshua Aviram, Yelena Vysotski, Salvatore Campisi-Pinto, Gil M. Lewitus, David Meiri
Publikováno v:
Rambam Maimonides Medical Journal, Vol 11, Iss 1, p e0001 (2020)
Objective The aim of this cross-sectional questionnaire-based study was to identify associations between the doses of cannabinoids and terpenes administered, and symptoms of attention deficit hyperactivity disorder (ADHD). Methods Participants wer
Externí odkaz:
https://doaj.org/article/e7279373bdff4449bf6ca6ae83aa87f4
Autor:
Joshua Aviram, Gil M. Lewitus, Yelena Vysotski, Anton Uribayev, Shiri Procaccia, Idan Cohen, Anca Leibovici, Mahmud Abo-Amna, Luiza Akria, Dmitry Goncharov, Neomi Mativ, Avia Kauffman, Ayelet Shai, Or Hazan, Gil Bar-Sela, David Meiri
Publikováno v:
Pharmaceuticals, Vol 13, Iss 12, p 435 (2020)
In the last decade the use of medical cannabis (MC) for palliative cancer treatment has risen. However, the choice between products is arbitrary and most patients are using Tetrahydrocannabinol (THC)-dominant cannabis products. In this study, we aime
Externí odkaz:
https://doaj.org/article/d74e246789a745cbb048bc92c942b028
Publikováno v:
Brain Sciences, Vol 10, Iss 6, p 360 (2020)
Background: Medical cannabis (MC) treatment for migraine is practically emerging, although sufficient clinical data are not available for this indication. This cross-sectional questionnaire-based study aimed to investigate the associations between ph
Externí odkaz:
https://doaj.org/article/f92021260f344f8988440ecba7e2a5d5
Autor:
Dorit Pud, Eelena Broitman, Omar Hameed, Erica Suzan, Joshua Aviram, May Haddad, Salim Hadad, Rafi Shemesh, Elon Eisenberg
Publikováno v:
PAIN Reports, Vol 2, Iss 3, p e593 (2017)
Abstract. Introduction:. We recently showed that the psycho-stimulant norepinephrine–dopamine reuptake inhibitor methylphenidate (MP) prolonged cold pain threshold and tolerance in adults with attention-deficit hyperactivity disorder (ADHD). Object
Externí odkaz:
https://doaj.org/article/6329c29877184918952088f2bf6508d1
Publikováno v:
Pain Practice. 23:145-154
Attaining good outcomes in the management of chronic pain remains a clinical challenge. This study aimed to investigate the relationships between - and the contribution of - pain and related conditions to the wellness of these patients.A secondary an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29143e4ad314ed181ec9ab15126befaf
https://doi.org/10.1111/papr.13168
https://doi.org/10.1111/papr.13168